Smartphone-Delivered Cognitive Behavioral Digital Therapeutic for Children and Adolescents With Major Depressive Disorder: Protocol for a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (Preprint)
Preprint
- 3 June 2026
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Depression is a leading contributor to morbidity and disability in children and adolescents. Cognitive behavioral therapy (CBT) is a guideline-recommended first-line treatment, but access is constrained by therapist supply, distance, and stigma. Internet-based CBT is a scalable adjunct in adults, yet regulatory-grade evidence in Chinese pediatric samples remains limited. OBJECTIVE This trial will determine whether a smartphone-delivered CBT-based digital therapeutic is superior to a matched health-education placebo in reducing depressive symptoms in Chinese children and adolescents with major depressive disorder (MDD), and characterize its safety. METHODS This is a prospective, multicenter, double-blind, placebo-controlled superiority trial at 4 tertiary-A hospitals in mainland China. Children and adolescents aged 8-17 years meeting DSM-5 (Diagnostic and Statistical Manual of Mental Disorders [Fifth Edition]) criteria for current MDD without psychotic features and scoring above 30 on the Children’s Depression Rating Scale-Revised (CDRS-R) at screening will be randomized 1:1 to the investigational digital therapeutic (Model WL-PD) or a visually matched health-education placebo. Both arms receive 8 weeks of structured content on an identical schedule; participants with CDRS-R ≥57 additionally receive open-label fluoxetine under weight-banded dosing. The primary end point is CDRS-R total-score reduction from baseline to week 8. Secondary end points include CDRS-R change at weeks 1 to 6; response and remission rates; Clinical Global Impression scores; the Children’s Depression Inventory; the Conners’ Parent Symptom Questionnaire; and a week-8 device-performance evaluation. Safety end points include adverse-event, serious adverse-event, and device-defect incidence. The planned sample of 214 participants (107 per arm) is powered at 80% to detect a between-arm difference of 4.6 CDRS-R points (assumed control SD 10.7) with a 1-sided α of .025 and 20% inflation for attrition. The primary analysis is an analysis of covariance on the full analysis set adjusting for baseline CDRS-R, severity category, fluoxetine exposure, and site; superiority is declared if the lower bound of the 2-sided 95% CI excludes zero, with a mixed model for repeated measures as a sensitivity analysis. RESULTS The trial opened to enrollment in March 2026; recruitment is ongoing, with a planned close in December 2026. The last week-8 visit is expected in the first quarter of 2027, and the primary analysis the following year. CONCLUSIONS The trial addresses 3 recognized gaps in the pediatric digital therapeutics literature: a rigorous, structurally matched blinded control condition, recruitment beyond a single site, and integration of guideline-concordant pharmacotherapy. Because recruitment is confined to tertiary hospitals and excludes participants with prominent suicidality or comorbidity, findings will apply to supervised use in specialist services rather than unselected community care. CLINICALTRIAL Chinese Clinical Trial Registry ChiCTR2600120453; https://tinyurl.com/3xzaajhp INTERNATIONAL REGISTERED REPORT DERR1-10.2196/103430Keywords
All Related Versions
- Published version: JMIR Research Protocols, 15, e103430.
This publication has 11 references indexed in Scilit:
- Effectiveness and Acceptability of Cognitive Behavior Therapy Delivery Formats in Adults With DepressionJAMA Psychiatry, 2019
- DepressionThe Lancet, 2018
- Health for the World's Adolescents: A Second Chance in the Second DecadeJournal of Adolescent Health, 2015
- A Pilot Double Blind Randomized Placebo Controlled Trial of a Prototype Computer-Based Cognitive Behavioural Therapy Program for Adolescents with Symptoms of DepressionBehavioural and Cognitive Psychotherapy, 2012
- Psychiatric rating scales2012
- Recovery and Recurrence Following Treatment for Adolescent Major DepressionArchives of General Psychiatry, 2011
- A Psychometric Evaluation of the CDRS and MADRS in Assessing Depressive Symptoms in ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 2007
- Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity DataJournal of the American Academy of Child & Adolescent Psychiatry, 1997
- Normative data on Revised Conners Parent and Teacher Rating ScalesJournal of Abnormal Child Psychology, 1978
- ECDEU Assessment Manual1976